semaglutide assessments GLP-1 Treatment Specialist Semaglutide slows epigenetic aging in

This was demonstrated in two randomised controlled trials (RCTs) that showed a decrease in epicardial adipose tissue in patients with T2D and obesity on liraglutide and exenatide according to echocardiography and cardiac MRI

Oral supplements might not work, so injections or sublingual tablets are better

Cells 13:1500

However, the risk of aspiration due to delayed gastric emptying has raised concern regarding the safety of GLP-1 agonists in the perioperative setting : The ANZCA Safety and Quality Committee recently presented two case reports of gastric contents identified on elective gastroscopy in patients using GLP-1 agonists despite adequate fasting times

GLP-1 therapy is not about jumping to the highest dose

Speaker 1 (01:24): Not yet